Valion Bio says IACUC clears AFRRI-run Entolimod radiation-injury study in mice
VBIO•Therapeutic study and data timing
Valion Bio said the therapeutic study will follow, with top-line data expected in early fall.
AFRRI mouse study cleared to begin
Valion Bio said a U.S. government-funded AFRRI/NIAID program is evaluating Entolimod for lethal radiation-induced gastrointestinal injury.
The company said IACUC approval has been secured for the AFRRI mouse studies, and a safety study is set to start this week.
